Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Esaki

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Nihon Naibunpi Gakkai Zasshi|January 20, 1978
[Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)]H Tamai, H Suematsu, H Takahashi, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injuryY Nuki, J Umeno, E Washio, et al.
Die Pharmazie|July 14, 2018
Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosingT Nakashima, K Koido, H Baba, et al.
Placenta|April 12, 2002
Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblastsK Udagawa, H Yasumitsu, M Esaki, et al.
Internal Medicine (Tokyo, Japan)|June 18, 1998
Primary cardiac leiomyosarcoma growing rapidly and causing right ventricular outflow obstructionM Esaki, K Kagawa, T Noda, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2017
Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trialH Nakase, S Motoya, T Matsumoto, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Nihon Naibunpi Gakkai Zasshi|January 20, 1978
[Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)]H Tamai, H Suematsu, H Takahashi, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injuryY Nuki, J Umeno, E Washio, et al.
Die Pharmazie|July 14, 2018
Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosingT Nakashima, K Koido, H Baba, et al.
Placenta|April 12, 2002
Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblastsK Udagawa, H Yasumitsu, M Esaki, et al.
Internal Medicine (Tokyo, Japan)|June 18, 1998
Primary cardiac leiomyosarcoma growing rapidly and causing right ventricular outflow obstructionM Esaki, K Kagawa, T Noda, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2017
Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trialH Nakase, S Motoya, T Matsumoto, et al.
Pageof 7